A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients-Reference-Cited by-同舟云学术

A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients

Published:2016-08-10 Issue:5 Volume:175 Page:1073-1075
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Chen A.C.¹²,Martin A.J.³,Dalziell R.A.¹,McKenzie C.A.⁴,Lowe P.M.²⁵,Eris J.M.²⁶,Scolyer R.A.²⁴⁷,Dhillon H.M.⁸,Vardy J.L.⁸⁹¹⁰,Bielski V.A.⁶,Halliday G.M.¹²,Damian D.L.¹²⁷

Affiliation:

1. Dermatology and Bosch Institute; University of Sydney at Royal Prince Alfred Hospital; Camperdown Australia

2. Central Clinical School; Sydney Medical School; University of Sydney; Sydney Australia

3. NHMRC Clinical Trials Centre; University of Sydney; Camperdown Australia

4. Tissue Pathology and Diagnostic Oncology; Royal Prince Alfred Hospital; Sydney Australia

5. Department of Dermatology; Royal Prince Alfred Hospital; Sydney Australia

6. Renal Medicine; Royal Prince Alfred Hospital; Sydney Australia

7. Melanoma Institute Australia; Sydney Australia

8. Centre for Medical Psychology and Evidence-Based Decision-Making; University of Sydney; Sydney Australia

9. Sydney Medical School; Concord Clinical School; University of Sydney; Sydney Australia

10. Concord Repatriation General Hospital; Sydney Australia

Funder

Australasian College of Dermatologists Scientific Research Fund

Australian Postgraduate Award

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.14662/fullpdf

Reference11 articles.

1. A population-based study of skin cancer incidence and prevalence in renal transplant recipients;Moloney;Br J Dermatol,2006

2. Skin cancer in Australian heart transplant recipients;Ong;J Am Acad Dermatol,1999

3. Mammalian target of rapamycin (mTOR) inhibitors slow skin carcinogenesis, but impair wound healing;Feldmeyer;Br J Dermatol,2012

4. Retinoids in the chemoprevention of non-melanoma skin cancers: why, when and how;Bettoli;J Dermatolog Treat,2013

5. Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials;Chen;Br J Dermatol,2005

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology and Risk Factors of Actinic Keratosis. What Is New for the Management for Sun-Damaged Skin;Dermatology Practical & Conceptual;2024-08-07

2. Carcinoma escamoso cutáneo en pacientes trasplantados de órgano sólido: revisión de la literatura;Medicina Clínica;2024-07

3. Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets;Signal Transduction and Targeted Therapy;2024-06-19

4. Primary Cutaneous Melanoma—Management in 2024;Journal of Clinical Medicine;2024-03-11

5. Analysis of metformin, niacinamide, and niacin as skin cancer preventative medications in solid organ transplant recipients;Journal of the American Academy of Dermatology;2024-02